Search
for
Sort by
Research 121–150 of 1000+
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- [Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition].
- Natural Hair Growth Actives in The Market: A Comprehensive Review
- Natural Hair Growth Actives in The Market: A Comprehensive Review
- Redox-Modulatory and MET-Inhibitory Triad: Synergistic Cytotoxicity of L-cysteine, NAC, and MET Inhibition in Cervical Cancer Cells
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- The Potential of Herbal Agents for Hair Growth: A Mechanism-Based Review of Hair Follicle Stimulation
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Role of the soluble epoxide hydrolase in the hair follicle stem cell homeostasis and hair growth
- Standardization of Amarantha hair oil with special reference to identification of β-sitosterol as major component having 5α-reductase inhibitory activity/hair growth promoting activity
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy
- Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
- May the best wound WIHN: the hallmarks of wound-induced hair neogenesis
- Corticotropin-Releasing Factor Down-Regulates Hair Growth-Related Cytokines in Cultured Human Dermal Papilla Cells
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- FGF signaling for hair cycle resting phase alleviates radiation alopecia
- 1338 Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex
- Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Polyamines and hair: a couple in search of perfection
- Inhibition of CCAAT/Enhancer Binding Protein Family DNA Binding in Mouse Epidermis Prevents and Regresses Papillomas
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor